Development of Monoclonal Antibodies in China: Overview and Prospects

Monoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents. Yet, current research concentrates on technology itself and pays attention to developed countries. This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis o...

Full description

Bibliographic Details
Main Authors:	Mao-Yu Zhang, Jin-Jian Lu, Liang Wang, Zi-Chao Gao, Hao Hu, Carolina Oi Lam Ung, Yi-Tao Wang
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2015/168935

id	doaj-a370b195271642628c68a7251aa73d67
record_format	Article
spelling	doaj-a370b195271642628c68a7251aa73d672020-11-24T21:05:55ZengHindawi LimitedBioMed Research International2314-61332314-61412015-01-01201510.1155/2015/168935168935Development of Monoclonal Antibodies in China: Overview and ProspectsMao-Yu Zhang0Jin-Jian Lu1Liang Wang2Zi-Chao Gao3Hao Hu4Carolina Oi Lam Ung5Yi-Tao Wang6State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, MacauMonoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents. Yet, current research concentrates on technology itself and pays attention to developed countries. This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis of drug registry, patent applications, clinical trials, academic publication, and ongoing R&D projects. The trends in therapeutic areas and industrialization process are also highlighted. Development and research trends of mAbs are analyzed to provide a future perspective of mAbs as therapeutic agents in China.http://dx.doi.org/10.1155/2015/168935
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Mao-Yu Zhang Jin-Jian Lu Liang Wang Zi-Chao Gao Hao Hu Carolina Oi Lam Ung Yi-Tao Wang
spellingShingle	Mao-Yu Zhang Jin-Jian Lu Liang Wang Zi-Chao Gao Hao Hu Carolina Oi Lam Ung Yi-Tao Wang Development of Monoclonal Antibodies in China: Overview and Prospects BioMed Research International
author_facet	Mao-Yu Zhang Jin-Jian Lu Liang Wang Zi-Chao Gao Hao Hu Carolina Oi Lam Ung Yi-Tao Wang
author_sort	Mao-Yu Zhang
title	Development of Monoclonal Antibodies in China: Overview and Prospects
title_short	Development of Monoclonal Antibodies in China: Overview and Prospects
title_full	Development of Monoclonal Antibodies in China: Overview and Prospects
title_fullStr	Development of Monoclonal Antibodies in China: Overview and Prospects
title_full_unstemmed	Development of Monoclonal Antibodies in China: Overview and Prospects
title_sort	development of monoclonal antibodies in china: overview and prospects
publisher	Hindawi Limited
series	BioMed Research International
issn	2314-6133 2314-6141
publishDate	2015-01-01
description	Monoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents. Yet, current research concentrates on technology itself and pays attention to developed countries. This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis of drug registry, patent applications, clinical trials, academic publication, and ongoing R&D projects. The trends in therapeutic areas and industrialization process are also highlighted. Development and research trends of mAbs are analyzed to provide a future perspective of mAbs as therapeutic agents in China.
url	http://dx.doi.org/10.1155/2015/168935
work_keys_str_mv	AT maoyuzhang developmentofmonoclonalantibodiesinchinaoverviewandprospects AT jinjianlu developmentofmonoclonalantibodiesinchinaoverviewandprospects AT liangwang developmentofmonoclonalantibodiesinchinaoverviewandprospects AT zichaogao developmentofmonoclonalantibodiesinchinaoverviewandprospects AT haohu developmentofmonoclonalantibodiesinchinaoverviewandprospects AT carolinaoilamung developmentofmonoclonalantibodiesinchinaoverviewandprospects AT yitaowang developmentofmonoclonalantibodiesinchinaoverviewandprospects
_version_	1716767449345425408

Development of Monoclonal Antibodies in China: Overview and Prospects

Similar Items